Saturday, June 14, 2025

Top 5 This Week

Related Posts

Sidra Medicine launches Qatar’s first cord blood bank

Sidra Medicine has recently launched the country’s first cord-blood banking service which will offer families a unique opportunity to preserve families’ newborns’ stem cells in Qatar, for potential future medical needs. This has been under a partnership with CellSave Arabia, a leading name in the field of biotechnology research.

Cord blood banking is the process of collecting and storing the blood from a newborn’s umbilical cord and placenta after birth. The collection is painless, non-invasive, and risk-free for the mother and baby. Cord blood is rich in hematopoietic stem cells, which have the potential to treat various medical conditions, including certain cancers, blood disorders, and immune system diseases.

Professor Johnny Awwad, chair of women’s services at Sidra Medicine said: “As the only facility in Qatar providing local cord blood storage, Sidra Medicine offers an unparalleled advantage by keeping the samples in the country. This ensures their optimal quality and immediate access when needed most, compared to having them shipped from abroad. Cord blood is increasingly being stored by parents everywhere, who are seeking to preserve their child’s stem cells as they can be crucial for their child or their sibling/s in the future. Our commitment to the latest technology and international standards further guarantees the utmost reliability and peace of mind for families in Qatar.”

Sidra Medicine Cord Blood Bank

All the cord blood samples will be sent to Sidra Medicine’s Cord Blood Bank in its Good Manufacturing Practice (GMP) facility, where cryogenic freezing will allow them to be stored securely for over 30 years.

To expand its reach to other families in Qatar, Sidra Medicine signed a Memorandum of Understanding (MoU) with CellSave Arabia, and the services are available to any family in the country choosing the joint Sidra Medicine and CellSave Arabia service as their stem cell storage provider regardless of whichever hospital their baby is born in. Alia Abdel-Razeq, COO of CellSave Arabia said at the MoU signing ceremony with Sidra Medicine: “Partnering with Sidra Medicine marks a pivotal step in our commitment to healthcare innovation in Qatar. By utilizing Sidra Medicine’s exceptional facilities and expertise, we can significantly elevate our service offerings, ensuring that families in Qatar have access to vital stem cell banking services that support their future health needs.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles